Compounds > cd 437
Page last updated: 2024-09-04

cd 437 and gsk 2126458

cd 437 has been researched along with gsk 2126458 in 1 studies

Compound Research Comparison

Studies
(cd 437)		Trials
(cd 437)		Recent Studies (post-2010)
(cd 437)		Studies
(gsk 2126458)		Trials
(gsk 2126458)		Recent Studies (post-2010) (gsk 2126458)
13402649243

Protein Interaction Comparison

ProteinTaxonomycd 437 (IC50)gsk 2126458 (IC50)
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoformHomo sapiens (human)0.0014
Cytochrome P450 1A2Homo sapiens (human)0.0012
Cytochrome P450 3A4Homo sapiens (human)0.0016
Alpha-2B adrenergic receptorRattus norvegicus (Norway rat)0.0012
Alpha-2C adrenergic receptorRattus norvegicus (Norway rat)0.0012
Alpha-2A adrenergic receptorRattus norvegicus (Norway rat)0.0012
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoformHomo sapiens (human)0.0006
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoformHomo sapiens (human)0.0009
Serine/threonine-protein kinase mTORHomo sapiens (human)0.0006
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)0.0007
Rapamycin-insensitive companion of mTORHomo sapiens (human)0.0002
Target of rapamycin complex 2 subunit MAPKAP1Homo sapiens (human)0.0002
Target of rapamycin complex subunit LST8Homo sapiens (human)0.0002

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ1

Other Studies

1 other study(ies) available for cd 437 and gsk 2126458

ArticleYear
Identification of potent Yes1 kinase inhibitors using a library screening approach.
    Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

    Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013